Literature DB >> 17095716

The roles of proteinase-activated receptors in the vascular physiology and pathophysiology.

Katsuya Hirano1.   

Abstract

Proteinase-activated receptors (PARs) belong to a family of G protein-coupled receptors, thus mediating the cellular effects of proteinases. In the vascular system, thrombin and other proteinases in the coagulation-fibrinolysis system are considered to be the physiologically relevant agonists, whereas PARs are among the most important mechanisms mediating the interaction between the coagulation-fibrinolysis system and the vascular wall. Under physiological conditions, PARs are mainly expressed in endothelial cells, and participate in the regulation of vascular tone, mostly by inducing endothelium-dependent relaxation. PARs in endothelial cells are also suggested to contribute to a proinflammatory phenotypic conversion and an increase in the permeability of vascular lesions. In smooth muscle cells, PARs mediate contraction, migration, proliferation, hypertrophy, and production of the extracellular matrix, thereby contributing to the development of vascular lesions and the pathophysiology of such vascular diseases as atherosclerosis. However, the expression of PARs in the smooth muscle of normal arteries is limited. The upregulation of PARs in the smooth muscle is thus considered to be a key step for PARs to participate in the pathogenesis of vascular lesions. Elucidating the molecular mechanism regulating the PARs expression is therefore important to develop new strategies for the prevention and treatment of vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095716     DOI: 10.1161/01.ATV.0000251995.73307.2d

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  52 in total

1.  Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.

Authors:  Yoonjung Park; Jiyeon Yang; Hanrui Zhang; Xiaonai Chen; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2010-10-24       Impact factor: 17.165

2.  Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.

Authors:  Phillip C Delekta; Ingrid J Apel; Shufang Gu; Katy Siu; Yoshiyuki Hattori; Linda M McAllister-Lucas; Peter C Lucas
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.

Authors:  Huan Qiao; Yan Liu; Ruth A Veach; Lukasz Wylezinski; Jacek Hawiger
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

Review 4.  Extracellular matrix, inflammation, and the angiogenic response.

Authors:  Alicia G Arroyo; M Luisa Iruela-Arispe
Journal:  Cardiovasc Res       Date:  2010-02-12       Impact factor: 10.787

5.  Constriction of carotid arteries by urokinase-type plasminogen activator requires catalytic activity and is independent of NH(2)-terminal domains.

Authors:  Philip G Massey; Shinji Tanaka; Joshua M Buckler; Bo Jiang; Anton McCourtie; Kun Qian; Clifford Tom; April Stempien-Otero; Shan Wen; Ian Luttrell; Kanchan Chitaley; David A Dichek
Journal:  Thromb Haemost       Date:  2009-11       Impact factor: 5.249

6.  Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage.

Authors:  Katsuharu Kameda; Yuichiro Kikkawa; Mayumi Hirano; Satoshi Matsuo; Tomio Sasaki; Katsuya Hirano
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

7.  Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells.

Authors:  Maartje van den Biggelaar; Juan Ramon Hernández-Fernaud; Bart L van den Eshof; Lisa J Neilson; Alexander B Meijer; Koen Mertens; Sara Zanivan
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

8.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

9.  Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.

Authors:  Wei-Fan Chen; Jie-Jen Lee; Chao-Chien Chang; Kuan-Hong Lin; Shwu-Huey Wang; Joen-Rong Sheu
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

10.  Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control.

Authors:  Anna Aronovich; Dalit Tchorsh; Elias Shezen; Chava Rosen; Yael Klionsky; Sivan Cohen; Orna Tal; Uri Martinowitz; Helena Katchman; Smadar Eventov-Friedman; Ninette Amariglio; Jasmine Jacob-Hirsch; Gideon Rechavi; Yair Reisner
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.